Divence Penta

Authorised

This medicine is authorised for use in the European Union

Bovine respiratory syncytial virus, strain LYM-56, Live / Infectious bovine rhinotracheitis virus, strain CEDDEL, gE- tk- double-gene deleted, Live / Bovine parainfluenza virus 3, strain SF-4 Reisinger, Inactivated / Bovine viral diarrhoea virus 1, E2 recombinant protein / Bovine viral diarrhoea virus 2, E2 recombinant protein

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website. 

Product details

• Name of medicine:
  Divence Penta
• Active substance:
  Bovine parainfluenza virus 3, strain SF-4 Reisinger, Inactivated,Bovine respiratory syncytial virus, strain LYM-56, Live,Bovine viral diarrhoea virus 1, E2 recombinant protein,Bovine viral diarrhoea virus 2, E2 recombinant protein,Infectious bovine rhinotracheitis virus, strain CEDDEL, gE- tk- double-gene deleted, Live,
• International non-proprietary name (INN) or common name:
  Bovine respiratory syncytial virus, strain LYM-56, Live / Infectious bovine rhinotracheitis virus, strain CEDDEL, gE- tk- double-gene deleted, Live / Bovine parainfluenza virus 3, strain SF-4 Reisinger, Inactivated / Bovine viral diarrhoea virus 1, E2 recombinant protein / Bovine viral diarrhoea virus 2, E2 recombinant protein

Pharmacotherapeutic group

• Immunologicals for bovidae
• Live and inactivated viral vaccines

Authorisation details

• EMA product number:
  EMEA/V/C/006175

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Divence Penta

Reference Number: EMA/CVMP/43998/2024